R. Greil, B. Burtness, S. Laban, I. Brana, R. Mesia Nin, T. Fuereder, Å. Bratland, L. Licitra, T. Rordorf, A. Psyrri, A. Popovtzer, B. Hughes, M. Tahara, J. Lin, B. Gumuscu, N. Lerman, K.J. Harrington
{"title":"106P PD-L1阳性复发/转移性(R/M)头颈部鳞状细胞癌(HNSCC)的治疗测序:III期KEYNOTE-048研究的探索性分析","authors":"R. Greil, B. Burtness, S. Laban, I. Brana, R. Mesia Nin, T. Fuereder, Å. Bratland, L. Licitra, T. Rordorf, A. Psyrri, A. Popovtzer, B. Hughes, M. Tahara, J. Lin, B. Gumuscu, N. Lerman, K.J. Harrington","doi":"10.1016/j.iotech.2023.100578","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"115 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"106P Treatment sequencing in PD-L1–positive recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Exploratory analysis of the phase III KEYNOTE-048 study\",\"authors\":\"R. Greil, B. Burtness, S. Laban, I. Brana, R. Mesia Nin, T. Fuereder, Å. Bratland, L. Licitra, T. Rordorf, A. Psyrri, A. Popovtzer, B. Hughes, M. Tahara, J. Lin, B. Gumuscu, N. Lerman, K.J. Harrington\",\"doi\":\"10.1016/j.iotech.2023.100578\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":192507,\"journal\":{\"name\":\"Immuno-Oncology and Technology\",\"volume\":\"115 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-Oncology and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.iotech.2023.100578\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100578","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
106P Treatment sequencing in PD-L1–positive recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Exploratory analysis of the phase III KEYNOTE-048 study